# Cell-based Therapy for the Treatment of Kidney Disease

> **NCT04187625** · EARLY_PHASE1 · UNKNOWN · sponsor: **Brigham and Women's Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Kidney Diseases

## Interventions

- **BIOLOGICAL:** endothelial progenitor cell

## Key facts

- **NCT ID:** NCT04187625
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-01
- **Primary completion:** 2024-01-01
- **Final completion:** 2025-05-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2022-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04187625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04187625, "Cell-based Therapy for the Treatment of Kidney Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04187625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*